• American Medical Directors Association (AMDA). Pressure ulcers in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2008. 44 p. [57 references]

This is the current release of the guideline.

This guideline updates a previous version: American Medical Directors Association (AMDA). Pressure ulcers. Columbia (MD): American Medical Directors Association; 1996. 16 p.

Pressure ulcers

Note: Although other types of ulcers (diabetic, ischemic, venous) may be treated similarly, this guidance should not be construed as applying to their care.

Evaluation
Management
Prevention
Risk Assessment
Treatment

Dermatology
Geriatrics
Infectious Diseases
Internal Medicine
Nursing
Nutrition
Preventive Medicine
Surgery

Advanced Practice Nurses
Allied Health Personnel
Dietitians
Nurses
Pharmacists
Physician Assistants
Physicians
Social Workers

• To improve the quality of care delivered to patients in long-term care facilities
• To offer care providers and practitioners in long-term care facilities a systematic approach to recognizing, assessing, treating, and monitoring patients with pressure ulcers

Elderly residents of long-term care facilities with or at risk of pressure ulcers

Recognition/Assessment

1. Examination of the patient's skin thoroughly to identify pressure ulcers
2. Assessment for risk factors for developing pressure ulcers such as comorbid conditions, drugs that may affect ulcer healing, history of pressure ulcers, impaired or decreased mobility and others using risk assessment instruments (e.g., the Braden Scale for Predicting Pressure Sores, the Norton Score)
3. Assessment of the patients overall physical and psychosocial health and characterization (staging) of the pressure ulcer
4. Identification of physiologic, functional, and psychosocial factors that can affect ulcer treatment and healing
5. Identification of priorities in managing the ulcer and the patient including identification and treatment of causative factors and modifiable comorbid conditions, optimal nutritional support, prevention and management of infection of the ulcer and others

Treatment/Prevention

1. Establishment of a realistic, individualized interdisciplinary care plan
2. Provision of general support for the patient including hydration, nutrition, pain management, and psychosocial support
3. Management of pressure by proper positioning, turning and transferring techniques; using appropriate positioning devices, support surfaces, and offloading devices; maintaining the lowest possible head elevation
4. Management of infection using topical antibiotics (e.g., bacitracin-polymyxin) if indicated or silver dressing
5. Debridement of necrotic tissue from the ulcer (autolytic, enzymatic, mechanical, surgical)
6. Covering and protecting the ulcer and surrounding skin using appropriate ulcer care products and dressings
7. Management of comorbid conditions (e.g., anemia, chronic obstructive pulmonary disease, diabetes, heart failure, peripheral vascular disease) that may contribute to pressure ulcer risk

Monitoring

1. Monitoring and documentation of the patient's progress and ulcer healing
2. Recognition and management of ulcer complications such as increasing necrosis, infection, cellulitis
3. Reassessment of treatment and change in approaches if indicated; consideration of surgery and adjunctive therapies (e.g., negative pressure wound therapy)
4. Monitoring of the facility's management of pressure ulcers using specific indicators

• Prevalence and incidence of pressure ulcers in long-term care settings
• Reliability and validity of risk assessment tools for pressure ulcers
• Efficacy of intervention measures
• Time to healing

Searches of Electronic Databases

Not stated

Not stated

Expert Consensus

Not applicable

Review
Review of Published Meta-Analyses

Not stated

Expert Consensus

The guideline was developed by an interdisciplinary workgroup using a process that combined evidence- and consensus-based approaches. The workgroups included practitioners and others involved in patient care in long-term care facilities. Beginning with a general guideline developed by an agency, association, or organization such as the Agency for Healthcare Research and Quality (AHRQ), pertinent articles and information, and a draft outline, the group worked to make a concise, usable guideline that is tailored to the long-term care setting. Because scientific research in the long-term care population is limited, many recommendations were based on the expert opinion of practitioners in the field.

Not applicable

Guideline developers reviewed a published cost analysis.

External Peer Review
Internal Peer Review

Guideline revisions were completed under the direction of the Clinical Practice Guideline Steering Committee. The committee incorporated information published in peer-reviewed journals after the original guidelines appeared, as well as comments and recommendations not only from experts in the field addressed by the guideline but also from "hands-on" long-term care practitioners and staff.

All American Medical Directors Association (AMDA) clinical practice guidelines undergo external review. The draft guideline is sent to approximately 175+ reviewers. These reviewers include AMDA physician members and independent physicians, specialists, nurse practitioners, pharmacists, nurses, consultants in the specified area, and organizations that are knowledgeable of the guideline topic and the long-term care setting.

The type of evidence supporting the recommendations is not specifically stated.

The guideline was developed by an interdisciplinary work group using a process that combined evidence- and consensus-based thinking.

By following essential steps and providing appropriate care of both the patient and the wound, pressure ulcers are most likely to be effectively prevented and treated. Consistent and correct performance of the basic measures discussed in this guideline can help facilities demonstrate that they did everything reasonable to try to prevent pressure ulcers and heal existing ones.

Not stated

• Autolytic debridement is contraindicated in ulcers with local infection of surrounding tissues.
• Negative-pressure wound therapy (NPWT) should not be used in the presence of osteomyelitis, in necrotic ulcers with eschar, if there is a fistula within the ulcer cavity, or if the ulcer is bleeding more than minimally.

• This clinical practice guideline is provided for discussion and educational purposes only and should not be used or in any way relied upon without consultation with and supervision of a qualified physician based on the case history and medical condition of a particular patient. The American Medical Directors Association and the American Health Care Association, their heirs, executors, administrators, successors, and assigns hereby disclaim any and all liability for damages of whatever kind resulting from the use, negligent or otherwise, of this clinical practice guideline.
• The utilization of the American Medical Directors Association's Clinical Practice Guideline does not preclude compliance with State and Federal regulation as well as facility policies and procedures. They are not substitutes for the experience and judgment of clinicians and caregivers. The Clinical Practice Guidelines are not to be considered as standards of care but are developed to enhance the clinicians' ability to practice.
• AMDA guidelines emphasize key care processes and are organized for ready incorporation into facility-specific policies and procedures to guide staff and practitioner practices and performance. They are meant to be used in a manner appropriate to the population and practice of a particular facility.

The implementation of this clinical practice guideline (CPG) is outlined in four phases. Each phase presents a series of steps, which should be carried out in the process of implementing the practices presented in this guideline. Each phase is summarized below.

1. Recognition
   • Define the area of improvement and determine if there is a CPG available for the defined area. Then evaluate the pertinence and feasibility of implementing the CPG

2. Assessment
   • Define the functions necessary for implementation and then educate and train staff. Assess and document performance and outcome indicators and then develop a system to measure outcomes

3. Implementation
   • Identify and document how each step of the CPG will be carried out and develop an implementation timetable
   • Identify individual responsible for each step of the CPG
   • Identify support systems that impact the direct care
   • Educate and train appropriate individuals in specific CPG implementation and then implement the CPG

4. Monitoring
   • Evaluate performance based on relevant indicators and identify areas for improvement
   • Evaluate the predefined performance measures and obtain and provide feedback

Guideline implementation will be affected by resources available in the facility, including staffing, and will require the involvement of all those in the facility who have a role in patient care.

Table 12 in the original guideline document provides ample performance measurement indicators and Appendix 1 provides suggested components of a staff training program in pressure ulcer prevention and management.

Getting Better
Living with Illness
Staying Healthy

Effectiveness
Patient-centeredness
Safety

• American Medical Directors Association (AMDA). Pressure ulcers in the long-term care setting. Columbia (MD): American Medical Directors Association (AMDA); 2008. 44 p. [57 references]

Not applicable: The guideline was not adapted from another source.

1996 (revised 2008)

American Medical Directors Association - Professional Association

Organizational participants included:

• American Association of Homes and Services for the Aging
• American College of Health Care Administrators
• American Geriatrics Society
• American Health Care Association
• American Society of Consultant Pharmacists
• National Association of Directors of Nursing Administration in Long-Term Care
• National Association of Geriatric Nursing Assistants
• National Conference of Gerontological Nurse Practitioners

Funding was supported by the following: Ross Products Division of Abbott Laboratories

Steering Committee

Committee Members: Lisa Cantrell, RN, C; Charles Cefalu, MD, MS; Sherrie Dornberger, RNC, CDONA, FDONA; Sandra Fitzler, RN; Joseph Gruber, RPh, FASCP, CGP; Marianna Grachek, MSN, CNHA, CALA; Susan M. Levy, MD, CMD; Evvie F. Munley; Jonathan Musher, MD, CMD; Barbara Resnick, PhD, CRNP; William Simonson, Pharm.D., FASCP, CGP

Not stated

This is the current release of the guideline.

This guideline updates a previous version: American Medical Directors Association (AMDA). Pressure ulcers. Columbia (MD): American Medical Directors Association; 1996. 16 p.

None available

None available

This summary was completed by ECRI on July 12, 1999. The information was verified by the American Medical Directors Association as of August 8, 1999. This summary was updated by ECRI Institute on May 20, 2008.

This NGC summary is based on the original guideline, which is copyrighted by the American Medical Directors Association (AMDA) and the American Health Care Association. Written permission from AMDA must be obtained to duplicate or disseminate information from the original guideline. For more information, contact AMDA at (410) 740-9743.